[ET Net News Agency, 1 June 2023] CLOVER BIO-B (02197) fell 1.75% to HK$1.12.
It hits an intra-day low of HK$1.12, hitting a historical low, and an intra-day high of
HK$1.18. The total shares traded was 4.55 million, with a value of HK$5.23m. The active
buy/sell ratio is 48:52, with net selling turnover of HK$157,025. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$378,776, with volume weighted
average price of HK$1.147. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$582,199, with volume weighted average price of HK$1.158.
The stock has fallen a combined 11.11% over the past 2 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 1.120 % Chg -1.75%
High 1.180 Low 1.120
Shares Tr 4.55m Turnover 5.23m
10-D SMA 1.326 %H.V 77.460
20-D SMA 1.510 VWAP 1.151
50-D SMA 1.690 RSI14 23.775
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 48:52, with net selling
turnover of HK$157,025, falling a combined 11.11% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CLOVER BIO-B (02197) 1.12 -1.75
GENSCRIPT BIO (01548) 17.50 +1.04
INNOVENT BIO (01801) 36.65 -0.14
JXR (01951) 4.10 +1.23
KEYMED BIO-B (02162) 41.20 +1.10
WUXI BIO (02269) 41.70 +4.12
TIGERMED (03347) 58.45 -0.43
BEIGENE (06160) 132.30 -0.68
ZAI LAB (09688) 26.00 +0.58
AKESO (09926) 35.00 +0.29
---------------------------------------------
(ed)